HCW Biologics Inc. short interest in 2024
In 2024, HCW Biologics Inc.'s disclosed short interest ran from 0.02% of shares outstanding on 12 Jan 2024 to 0.35% on 31 Dec 2024, a change of +0.33 percentage points. The year's high was 0.61% on 13 Dec 2024 and its low 0.01% on 31 Jan 2024, averaging 0.12% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.16 days on 30 Apr 2024. Full history: HCW Biologics Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 0.02% (12 Jan 2024)
- End of year
- 0.35% (31 Dec 2024)
- Change
- +0.33 pp
- High
- 0.61% (13 Dec 2024)
- Low
- 0.01% (31 Jan 2024)
- Average
- 0.12%
- Highest days to cover
- 2.16 (30 Apr 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 0.02% | 1.00 | |
| 31 Jan 2024 | 0.01% | 1.00 | |
| 15 Feb 2024 | 0.01% | 1.00 | |
| 28 Mar 2024 | 0.04% | 1.00 | |
| 15 Apr 2024 | 0.02% | 1.00 | 10-K filed, results (8-K) |
| 30 Apr 2024 | 0.02% | 2.16 | |
| 14 Jun 2024 | 0.01% | 1.00 | 10-Q filed, results (8-K) |
| 28 Jun 2024 | 0.02% | 1.00 | |
| 15 Jul 2024 | 0.02% | 1.00 | |
| 31 Jul 2024 | 0.02% | 1.18 | |
| 15 Aug 2024 | 0.03% | 1.20 | 10-Q filed, results (8-K) |
| 13 Sep 2024 | 0.03% | 1.00 | |
| 30 Sep 2024 | 0.07% | 1.62 | |
| 15 Oct 2024 | 0.07% | 1.00 | |
| 15 Nov 2024 | 0.38% | 1.00 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 0.34% | 1.00 | |
| 13 Dec 2024 | 0.61% | 1.00 | |
| 31 Dec 2024 | 0.35% | 1.00 |
See also: HCW Biologics Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.